NUCLEOLIN and glioma: Taken together, these literature indications in concert with our data suggest that — in addition to its effect on tumor cell proliferation — oncofetal NCL may regulate brain tumor vascularization and could be a candidate for targeted therapy on both tumor and ECs in human gliomas.